Results
1 -
5 of
5Multi-kinase inhibitors, AURKs and cancer, Medical Oncology Pharmacokinetics Study of the Antitumor Drug CYC-116 in Rat Plasma by Using LCu2013MS Analysis, Chromatographia An integrated pharmacokineticu2013pharmacodynamic model for an Aurora kinase inhibitor, Journal of Pharmacokinetics and Pharmacodynamics Matrine and CYC116 synergistically inhibit growth and induce apoptosis in multiple myeloma cells, Chinese Journal of Integrative Medicine Aurora kinase inhibitors: Progress towards the clinic, Investigational New Drugs